Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Goldgroup Mining Inc.
GORO
$191M
| $497K | ﹤0.01% |
120,783
+32,873
| +37% | +$127K |
|
3302
American Vanguard Corp
AVD
$68.9M
| $495K | ﹤0.01% |
35,971
+2,691
| +8% | +$36.1K |
|
3303
CALL
Vanguard FTSE Emerging Markets ETF
VWO
$124B
| $495K | ﹤0.01% |
12,500
-208,300
| -94% | -$7.71M |
|
3304
ProShares Ultra QQQ
QLD
$14.1B
| $494K | ﹤0.01% |
+26,744
| New | +$410K |
|
3305
American Coastal Insurance
ACIC
$493M
| $493K | ﹤0.01% |
62,957
+14,680
| +30% | +$119K |
|
3306
PUT
AptarGroup
ATR
$8.61B
| $493K | ﹤0.01% |
4,400
-3,600
| -45% | -$383K |
|
3307
CALL
Hartford Financial Services
HIG
$39.3B
| $493K | ﹤0.01% |
12,800
+2,300
| +22% | +$87.6K |
|
|
ATRI
3308
DELISTED
Atrion Corp
ATRI
| $493K | ﹤0.01% |
775
+298
| +62% | +$195K |
|
|
CTT
3309
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $493K | ﹤0.01% |
55,660
+39,373
| +242% | +$305K |
|
3310
Rayonier
RYN
$6.55B
| $491K | ﹤0.01% |
21,860
+7,414
| +51% | +$161K |
|
3311
CALL
Pinterest
PINS
$13.4B
| $490K | ﹤0.01% |
22,100
-74,100
| -77% | -$1.45M |
|
3312
Phibro Animal Health
PAHC
$1.39B
| $489K | ﹤0.01% |
18,571
+1,764
| +10% | +$43.8K |
|
3313
CALL
Boston Properties
BXP
$11.1B
| $488K | ﹤0.01% |
5,400
| – | – |
|
3314
CALL
D.R. Horton
DHI
$42.3B
| $488K | ﹤0.01% |
8,800
-51,900
| -86% | -$2.52M |
|
|
CLVS
3315
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $488K | ﹤0.01% |
72,400
-27,600
| -28% | -$209K |
|
3316
CALL
Newmont
NEM
$119B
| $486K | ﹤0.01% |
7,868
-145,200
| -95% | -$8.59M |
|
3317
CALL
Centene
CNC
$32.5B
| $485K | ﹤0.01% |
7,638
-178,800
| -96% | -$11.6M |
|
3318
PUT
State Street SPDR S&P Metals & Mining ETF
XME
$4.42B
| $485K | ﹤0.01% |
22,900
-44,500
| -66% | -$879K |
|
|
CNSL
3319
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $484K | ﹤0.01% |
71,618
+3,714
| +5% | +$21.8K |
|
|
SDRL
3320
DELISTED
Seadrill Limited Common Stock
SDRL
| $484K | ﹤0.01% |
1,126,536
+1,028,908
| +1,054% | +$554K |
|
3321
Independent Bank Corp
IBCP
$844M
| $483K | ﹤0.01% |
32,588
+18,170
| +126% | +$251K |
|
3322
CALL
Toronto Dominion Bank
TD
$200B
| $482K | ﹤0.01% |
10,800
-8,000
| -43% | -$341K |
|
|
DAY
3323
DELISTED
Dayforce
DAY
| $482K | ﹤0.01% |
6,082
+918
| +18% | +$58.9K |
|
3324
The RMR Group
RMR
$332M
| $481K | ﹤0.01% |
16,293
+4,602
| +39% | +$133K |
|
|
SKX
3325
PUT
DELISTED
Skechers
SKX
| $480K | ﹤0.01% |
15,300
-27,200
| -64% | -$780K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.